| The 2007 Fleshner
                nomogram
 [Dr. Shaw's personal website]
 Purpose:
                an experimental tool to evaluate post-biopsy D'Amico or JUA low-risk cancers...candidates for
                brachytherapy or watchful waiting (active surveillance)...to predict from biopsy & clinical
                parameters the likelihood that findings in a prostatectomy of that case would cause a
                postoperative  Gleason upgrade (nomogram helps avoid under-treatment by flagging cases for
                further consideration of advisability of caution about any conservative management
                option).
 NOTE: the nomogram does not know how to "back out"
                the inflammatory portion of elevated PSA, if the case has significant prostatitis
                [S07-6946].
 Factors needed to work the
                      nomogram: patient's age, total serum PSA value, whether the pathologist is highly
                      experienced at reading prostate core biopsies (uro-path) or not (other), whether urologist's
                      DRE exam of patient is normal or not, whether biopsies contained any PIN or not, the prostate
                      volume by TRUS calculation, whether TRUS exam found any hypoechoic areas (positive) or not
                      (negative), whether the biopsies were taken in a "sextant" 6-core procedure (systematic) or
                      an extended series (more than six biopsies) procedure, and the sum of all cancer segments
                      divided by the sum of lengths of all the biopsy cores (to calculate CA Percentage). For each
                      factor point/value, bring a vertical line upward to the  "points" line and note the
                      value where the lines intersect. Finally, sum the points for each factor and plot that sum on
                      the lower "total points" line. from that sum point, drop a vertical line to the "probability"
                      line below in order to see the probability that your case would contain Gleason upgrade if
                      the whole prostate were examined.   We recommend the journal,
                Cancer, and have placed this graphic on the website in order solely to make it more convenient for
                our uropathologists to use this nomogram in cases they wish to test.
 Dr. Shaw's
                personal WEB-FILE of info for
                prostate cancer patients & their "significant others" Our pathology group's TOC WEB-FILE on prostate cancer issues   Reference: et. al. & Fleshner
                Neil E. (Toronto, Canada), Clinical Predictors of Gleason Score Upgrading, Cancer 109(12):2432-38, June 15, 2007. The nomogram chart is on page
                   2436.
 ***give me your comments about this
                      page*** check out the Highest
                      TRUTH (posted 20 December 2007) |